Log In Sign up
The largest database of trusted experimental protocols

P fak tyr861

Manufactured by Abcam
Visit Supplier

P-FAK Tyr861 is a phospho-specific antibody that recognizes focal adhesion kinase (FAK) phosphorylated at tyrosine 861. FAK is a key regulator of cell signaling pathways involved in cell migration, adhesion, and survival.

Automatically generated - may contain errors

Lab products found in correlation

Af5888, by R&D Systems (2 mentions) P gsk3beta ser9, by Cell Signaling Technology (2 mentions) Murine anti β actin monoclonal antibody, by Merck Group (2 mentions) V5 and pan 14 3 3 antibody, by Abcam (2 mentions) P pi3k p110δ, by Cell Signaling Technology (2 mentions)

Spelling variants of this product

P-FAK (28 citations)

2 protocols using p fak tyr861

1

Immunoblotting Antibodies for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in this study: anti-human LNK antibody [AF5888, R&D system Inc, a sheep IgG against E.coli derived recombinant human LNK protein (amino acids 427–575)]; murine anti-β-actin monoclonal antibody (Sigma); V5 and pan 14-3-3 antibody (Abcam); antibodies against p-JAK2 (Tyr1007/1008), JAK2, p-p38 (Thr180/Tyr182), p-ERK1/2 (Thr202/Tyr204), p-JNK1/2 (Tyr183), p-PDK1 (Ser243), p-P70S6 (Thr421/Ser424), p-GSK3beta (Ser9), p-AKT (Ser473) and AKT, p-PI3K p110δ (Tyr485) (from either Cell Signaling Technology or Santa Cruz) and p-FAK Tyr861 (Epitomics).
Ding L.W., Sun Q.Y., Lin D.C., Chien W., Hattori N., Dong X.M., Gery S., Garg M., Doan N.B., Said J.W., Xiao J.F., Yang H., Liu L.Z., Meng X., Huang R.Y., Tang K, & Koeffler H.P. (2014). LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene, 34(11), 1463-1474.
+ Open protocol
+ Expand
2

Immunoblotting Antibodies for Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used in this study: anti-human LNK antibody [AF5888, R&D system Inc, a sheep IgG against E.coli derived recombinant human LNK protein (amino acids 427–575)]; murine anti-β-actin monoclonal antibody (Sigma); V5 and pan 14-3-3 antibody (Abcam); antibodies against p-JAK2 (Tyr1007/1008), JAK2, p-p38 (Thr180/Tyr182), p-ERK1/2 (Thr202/Tyr204), p-JNK1/2 (Tyr183), p-PDK1 (Ser243), p-P70S6 (Thr421/Ser424), p-GSK3beta (Ser9), p-AKT (Ser473) and AKT, p-PI3K p110δ (Tyr485) (from either Cell Signaling Technology or Santa Cruz) and p-FAK Tyr861 (Epitomics).
Ding L.W., Sun Q.Y., Lin D.C., Chien W., Hattori N., Dong X.M., Gery S., Garg M., Doan N.B., Said J.W., Xiao J.F., Yang H., Liu L.Z., Meng X., Huang R.Y., Tang K, & Koeffler H.P. (2014). LNK (SH2B3): paradoxical effects in ovarian cancer. Oncogene, 34(11), 1463-1474.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!